ACM
HAE icon

Americafirst Capital Management’s Haemonetics HAE Stock Holding History

Americafirst Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,477
Closed -$260K – 195
2016
Q4 		$260K Sell
6,477
-39,450
-86% -$1.49M 0.27% 107
2016
Q3 		$1.66M Buy
+45,927
New +$1.58M 1.38% 31

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Americafirst Capital Management's HAE Position: Q1 2017 in Review

Americafirst Capital Management sold out of Haemonetics (HAE) in Q1 2017, closing a stake of 6,477 shares — an estimated $260K sold.

Americafirst Capital Management first reported a position in HAE in Q3 2016 and held it in 2 quarters. The position peaked at $1.66M in Q3 2016. 181 funds tracked by Wall St. Rank hold HAE as of Q1 2017.

  • Americafirst Capital Management reported no remaining Haemonetics position as of Q1 2017 after selling out during the quarter.
  • Americafirst Capital Management sold 6,477 Haemonetics shares in Q1 2017, an estimated $260K.
  • Americafirst Capital Management first reported a position in Haemonetics in Q3 2016 and held it in 2 quarters.
  • Americafirst Capital Management's Haemonetics position peaked at $1.66M in Q3 2016.
  • 181 funds tracked by Wall St. Rank held Haemonetics as of Q1 2017.

Based on Americafirst Capital Management's 13F filing for Q1 2017, filed 17 Apr 2017.